Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03425266 · ClinicalTrials.gov registry record · NA

The Pain App Study: A Novel Shared Decision Making Tool for People With Chronic Pain

A NA study of Chronic Pain, sponsored by Shared Decision Making Resources.

Completed
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT03425266: Completed NA study of Chronic Pain, sponsored by Shared Decision Making Resources.

NCT03425266 is a NA study of Chronic Pain that has completed, run by Shared Decision Making Resources. The registered enrollment target is 80 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03425266, a NA study of Chronic Pain, has completed, sponsored by Shared Decision Making Resources.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The investigators seek to understand the preferences, goals, and perspectives of patients with chronic pain and their health care providers (HCPs) to create a patient-centered decision support tool. This tool, aimed at patients and HCPs, should improve patient-provider communication and chronic pain management. The investigators' long-term goal is to improve the quality of life of patients with chronic pain. The investigators target adults with chronic unremitting pain and HCPs who manage patients with chronic pain, including primary care providers and pain specialists. A pilot randomized controlled trial (RCT) will measure the impact of a new online tool that the investigators developed (Pain-APP) in a representative sample of adults with chronic pain, including approximately 50 patients and 4-15 HCPs. Eligible patients will be enrolled online, and after informed consent and eliciting baseline socio-demographic information, randomized online to either Pain-APP or the control group, which will consist of online educational materials at the ACPA website (https://theacpa.org/Communication-Tools). Patients in both groups will be assessed online before, just after viewing the intervention materials, just after the index clinic visit, and 1 month later. Patient-reported outcomes include patient-provider communication, pain intensity and interference, attitudes towards and use of opioid medication.

Primary Outcome

The study uses a composite measure comprised of the items from the CG CAHPS survey that relate to shared decision making, including self-reported patient-provider communication (explained things, listened carefully, showed respect, spent enough time), patient rating of provider, care coordination (provider knew important information about the patient's medical history), rating of overall health and overall mental or emotional health.

Conditions Studied

Interventions

  • OTHER Interactive decision support tool

Study Locations (1)

Maine

  • Shared Decision Making Resources - Georgetown

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2018-01-11
Est. Completion 2018-10-31
Phase NA
Shared Decision Making Resources

3 total trials

What the finished NCT03425266 record still lists

NCT03425266 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (90% lower).

The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which Interactive decision support tool is the first listed.

NCT03425266 reports a single indexed study location in Maine.

Frequently Asked Questions

What is clinical trial NCT03425266 about?

NCT03425266 is a clinical study titled "The Pain App Study: A Novel Shared Decision Making Tool for People With Chronic Pain". The investigators seek to understand the preferences, goals, and perspectives of patients with chronic pain and their health care providers (HCPs) to create a patient-centered decision support tool. This tool, aimed at patients and HCPs, should improve patient-provider communication and chronic pain...

What is the current status of trial NCT03425266?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2018-01-11. Estimated completion is 2018-10-31.

What conditions does trial NCT03425266 study?

This clinical trial studies the following conditions: Chronic Pain.

What interventions are being tested in trial NCT03425266?

The interventions under investigation include: Interactive decision support tool (OTHER).

Who is sponsoring clinical trial NCT03425266?

This trial is sponsored by Shared Decision Making Resources, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03425266 being conducted?

This trial has 1 study location across Maine. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03425266's enrollment target sits among peer trials

80 150th of 301 higher than 148 of 301 other Chronic Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03425266, the US trial registry maintained by the National Library of Medicine. NCT03425266 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.